Market closed
Seer/$SEER
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Seer
Seer Inc is a biotechnology company. The company commercializes transformative products for researchers to unlock deep, unbiased biological information. Its product, the Proteograph Product Suite (Proteograph), will leverage its proprietary engineered nanoparticle (NP) technology to provide unbiased, deep, rapid, and large-scale access across the proteome.
Ticker
$SEER
Sector
Trading on
Industry
Life Sciences Tools & Services
Headquarters
Employees
147
Website
Seer Metrics
BasicAdvanced
$137M
Market cap
-
P/E ratio
-$1.30
EPS
1.46
Beta
-
Dividend rate
Price and volume
Market cap
$137M
Beta
1.46
52-week high
$2.51
52-week low
$1.51
Average daily volume
277K
Financial strength
Current ratio
18.362
Quick ratio
17.663
Long term debt to equity
7.035
Total debt to equity
7.687
Management effectiveness
Return on assets (TTM)
-14.92%
Return on equity (TTM)
-22.03%
Valuation
Price to revenue (TTM)
10.104
Price to book
0.4
Price to tangible book (TTM)
0.4
Price to free cash flow (TTM)
-2.905
Growth
Revenue change (TTM)
-13.19%
Earnings per share change (TTM)
-9.33%
3-year revenue growth (CAGR)
55.47%
3-year earnings per share growth (CAGR)
1.24%
What the Analysts think about Seer
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Seer stock.
Seer Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Seer Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Seer News
AllArticlesVideos
Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™
GlobeNewsWire·4 weeks ago
Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific
GlobeNewsWire·1 month ago
Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer's, Lung Cancer, and More at ASHG 2024
GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Seer stock?
Seer (SEER) has a market cap of $137M as of December 21, 2024.
What is the P/E ratio for Seer stock?
The price to earnings (P/E) ratio for Seer (SEER) stock is 0 as of December 21, 2024.
Does Seer stock pay dividends?
No, Seer (SEER) stock does not pay dividends to its shareholders as of December 21, 2024.
When is the next Seer dividend payment date?
Seer (SEER) stock does not pay dividends to its shareholders.
What is the beta indicator for Seer?
Seer (SEER) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.